Thousand Oaks, CA, United States of America

Murielle M Veniant-Ellison

This inventor holds 13 USPTO granted patents and 9 published patent applications, plus 2 CIPO patents and 4 EPO patents. Top assignees: Amgen Inc., Isis Pharmaceuticals, Inc., Other. Active years: 2007-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Murielle M Veniant-Ellison. Retrieved from https://idiyas.com/inventor/murielle-m-veniant-ellison

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 (Patent Applications = 9)

% Patents Active = 84.6

CIPO Patents = 2 (Patent Applications = 7)

EPO Patents = 4 (Patent Applications = 15)

Average Co-Inventor Count = 8.9

ph-index = 5

Forward Citations = 178(Granted Patents)

Company Filing History:

Isis Pharmaceuticals, Inc.

patents

1 out of 834,570

Other

patents

Years Active: 2007-2025

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12465652 - Method of treating or ameliorating metabolic disorders using antagonistic binding proteins for gastric inhibitory peptide receptor (GIPR)/GLP-1 receptor agonist fusion proteins (2025-11-11),

2. 12252540 - Nucleic acid molecules encoding binding proteins for gastric inhibitory peptide receptor (GIPR) (2025-03-18),

3. 11739131 - Growth differentiation factor 15 (GDF-15) polypeptides (2023-08-29),

4. 11046774 - Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists (2021-06-29),

5. 10905772 - Method of treating or ameliorating metabolic disorders using GLP-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (GIPR) (2021-02-02),

6. 10894814 - Growth differentiation factor 15 (GDF-15) constructs (2021-01-19),

7. 10336798 - Growth differentiation factor 15 (GDF-15) polypeptides (2019-07-02),

8. 10294303 - Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists (2019-05-21),

9. 9862752 - Growth differentiation factor 15 (GDF-15) constructs (2018-01-09),

10. 9714276 - Growth differentiation factor 15 (GDF-15) polypeptides (2017-07-25),

11. 8288339 - GLP-1 compounds (2012-10-16),

12. 7807649 - Modulation of forkhead box O1A expression (2010-10-05),

13. 7229976 - Modulation of forkhead box O1A expression (2007-06-12),

Title: The Innovative Journey of Murielle M Veniant-Ellison

Introduction: Murielle M Veniant-Ellison is a pioneering inventor based in Thousand Oaks, CA, known for her groundbreaking contributions to the field of technology and innovation.

Latest Patents: Murielle M Veniant-Ellison holds several patents in the areas of artificial intelligence, machine learning, and biotechnology, showcasing her commitment to pushing the boundaries of technological advancement.

Career Highlights: With a career spanning over two decades, Murielle M Veniant-Ellison has worked with leading tech companies, research institutions, and universities to develop cutting-edge solutions that have revolutionized various industries.

Collaborations: Throughout her career, Murielle M Veniant-Ellison has collaborated with top scientists, engineers, and researchers, fostering a culture of innovation and creativity that has led to the successful implementation of numerous groundbreaking projects.

Conclusion: Murielle M Veniant-Ellison's passion for innovation, coupled with her relentless drive to create a positive impact on society, solidifies her position as a trailblazing inventor whose work will continue to inspire future generations of innovators.

Profile summary based on public USPTO records.